Mar 2018

UNIFIED ACCESS SYSTEM FOR MEDICAL CANNABIS NEEDED

Blue Mountains GP Dr Teresa Towpik has spoken out to encourage others to review the research supporting the therapeutic use of cannabis taking into account “observational evidence” from patients and carers.

Dr Towpik was unsuccessful in her attempts to prescribe a medicinal cannabis product for a patient with chronic pain and cautioned that patients trying to access medicinal cannabis may resort to the black and miss out on proper medical management.

State-based rules make it increasingly difficult to access medicinal cannabis with GPs including RACGP President Dr Bastian Seidel calling for a unified system of access.

Read the article here.

 

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >